XML 19 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Right-of-use Assets, Machinery and Equipment, Net, and Construction In Progress
 3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
Right-of-use Assets, Machinery and Equipment, Net, and Construction In Progress

4. Right-of-use assets, machinery and equipment, net, and construction in progress

 

As of March 31, 2021 and December 31, 2020, rights-of-use assets, machinery and equipment, net, and construction in progress were as follows (in thousands):

 

   

March 31, 2021

(unaudited)

     December 31, 2020  
Right-of-use assets (1)   $ 3,397     $ 3,397  
Machinery and equipment     2,597       2,480  
Accumulated depreciation and amortization     (1,679)       (1,440)  
Right-of-use assets, machinery and equipment, net     4,315       4,437  
Construction in progress     2,951       2,087  
Right-of-use assets, machinery and equipment, net, and construction in progress   $ 7,266     $ 6,524  

 

(1) Oncocyte recorded certain right-of-use assets and liabilities for operating leases in accordance with ASC 842 (see Notes 5 and 14).

 

Depreciation and amortization expense amounted to $239,000 and $60,000 for the three months ended March 31, 2021 and 2020, respectively.

 

Construction in progress

 

Construction in progress as of March 31, 2021 includes $2.9 million for leasehold improvements, consisting primarily of the costs incurred for the construction of Oncocyte’s primary laboratory facility at its Irvine, California headquarters. Of this amount, $1.1 million has been financed by the landlord and is included in landlord liability (see Note 14). Construction in progress is not depreciated until the underlying asset is placed into service.